Connect With a Global Community of 100+ Early RLT Experts

As radiopharmaceutical development rapidly expands toward a projected $26.5B market by 2031, teams still face persistent barriers - limited target diversity, suboptimal isotope–biology matching, translational uncertainty, and toxicity risks. Solution providers play a critical role in overcoming these roadblocks, and this summit is where those capabilities are actively sought.

At the 2nd Targeted Radiopharmaceuticals Target Selection & Drug Design Summit, partners connect directly with R&D leaders who need support in preclinical modeling, imaging, radioconjugation, delivery systems, targeting moieties, CRO services, and isotope supply to:

  • Broaden target strategies and move beyond PSMA/SSTR2
  • Improve tumor specificity and reduce off-target toxicity
  • Strengthen PK/dosimetry insights for cleaner Phase 0/FIH translation
why partner image

Key Services & Solutions

Our attendees from RLT biopharma are looking for service and solution providers with capabilities in the below areas but not limited to:

Preclinical
CROs

Help run early in-vitro and in-vivo studies to show whether a radiopharmaceutical is safe, effective, and ready to move toward the clinic.

Imaging & Modeling Providers

Use PET, SPECT, and dosimetry tools to visualize where a therapy goes in the body and predict how it will behave in humans.

Targeting & Delivery Specialists

Create antibodies, peptides, and other targeting vehicles that guide the radiopharmaceutical to the tumor while avoiding healthy tissue.

Radiochemistry & Conjugation Experts

Design and optimize the linker, chelator, and conjugation chemistry that keeps isotopes stable and ensures the payload reaches its target.

Isotope
Suppliers

Provide reliable access to the alpha, beta, and Auger isotopes needed for research, clinical development, and scaling into larger trials.

Translational & Dosimetry Partners

Help teams better understand dose, exposure, and safety so that first-in-human studies are faster, clearer, and less risky.

CDMOs

Offer GMP production, fill-finish, and scale-up expertise to support clinical supply and prepare programs for future commercial needs.

Software & Digital Technology Providers

Deliver tools that streamline imaging analysis, automate workflows, and support smarter decision-making throughout RLT development.

Hear What Our Past Sponsors Have to Say

Macrocylics

High quality presentations from very knowledgeable individuals from prominent companies in the industry.

Production Manager & Business Development Lead, Macrocyclics

Trasis

Excellent talks from major actors of the radiopharma/nuclear medicine field. Talks and discussions with partners allow for an accurate view of current as well as future market trends.

Radiometals & Radiochemistry Manager, Trasis SA

Audience Composition

Company Type

2nd TRP Target Selection & Drug Design Summit company stats

Attendee Seniority

2nd TRP Target Selection & Drug Design Summit audience composition

Attending Companies Include

Get in Touch

Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.

Mehmet Gul

Senior Partnerships Director

sponsor page image
Maintain Your Competitive Edge

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.

sponsor page image
Network With Decision-Makers

Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.

sponsor page image
Showcase Your Capabilities

Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.